Patent Oppositions in complex drugs industry

Explore the competitive field of complex drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in complex drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the complex drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the complex drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 1, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Method For Producing Cd8Alpha+Beta+Cytotoxic T CellsKYOTO UNIVERSITYJul 6, 2026MARGARET DIXON
A Method For High Level And Stable Gene Transfer In LymphocytesJULIUS MAXIMILIANS UNIVERSITT WRZBURGJul 3, 2026MAX DELBRUCK CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ GEMEINSCHAFT
Methods For Production Of Capsular Polysaccharide Protein Conjugates From Streptococcus Pneumoniae Serotype 19FMERCK SHARP & DOHMEJun 24, 2026SK BIOSCIENCE
Use Of Ahr Agonist For The Preventive Or Curative Treatment Of Metabolic Syndrome And The Associated DisordersINSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUEJun 3, 2026FUCHS
Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYOMay 20, 2026RIECK
Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYOMay 19, 2026NESTLE
Dietary Modulation Of Brain FunctioningNUTRICIAMay 12, 2026NESTLE
Compositions And Methods For Muscle Regeneration Using Prostaglandin E2THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYApr 22, 2026DORRIES
Compositions And Methods For The Treatment Of Graft Versus Host DiseaseVECTIVBIOApr 2, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Use Of Akkermansia For Treating Metabolic DisordersCOMPAGNIE GERVAIS DANONEFeb 6, 2026NESTLE

To stay ahead in the competitive complex drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the complex drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 1, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Aug 7, 2019Methods To Mobilize Progenitor/Stem CellsGENZYME7
Oct 19, 2016Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYO6
Jan 6, 2021Composition For Improving Membrane Composition And Functioning Of CellsNUTRICIA4
Nov 8, 2023Neoantigen Identification, Manufacture, And UseGRITSTONE BIO4
Apr 29, 2020Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYO4
Apr 29, 2020Composition For Inducing Proliferation Or Accumulation Of Regulatory CellsTHE UNIVERSITY OF TOKYO4
Oct 5, 2016Purified Mesenchymal Stem Cell Compositions And Methods Of Purifying Mesenchymal Stem Cell CompositionsOSIRIS THERAPEUTICS4
Oct 28, 2020High Energy Liquid Enteral Nutritional CompositionNUTRICIA4
Sep 16, 2015Liquid Enteral Nutritional Composition With A Low Monovalent Metal Ion ContentNUTRICIA3
Dec 6, 2017Immunostimulation By Chemically Modified RnaCUREVAC3